The corporate company Resaphene will henceforth cooperate with GEHE Pharma Handel in the distribution of the tinnitus therapy device Tinniwell. Starting in August 2018, Tinniwell will be introduced in the 800 highest-grossing pharmacies in Germany. Overall, GEHE has a network of 7,000 pharmacies that can be reached.

This is another step towards the professionalization of Resaphene's distribution channel. Currently, two additional distribution concepts are also being rolled out with ENT doctors in Germany and Switzerland.